Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Wyatt

Showing results (311-320 of 345) with videos related to

Pageof 35
Sort By:
JCI Insight|April 20, 2017
β-catenin and PI3Kδ inhibition expands precursor Th17 cells with heightened stemness and antitumor activityKinga Majchrzak, Michelle H Nelson, Jacob S Bowers, et al.
Kidney International|May 2, 2024
Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIVAnnegret Pelchen-Matthews, Amanda Mocroft, Lene Ryom, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 18, 2012
Comorbid diabetes and the risk of progressive chronic kidney disease in HIV-infected adults: data from the Veterans Aging Cohort StudyRaj K Medapalli, Chirag R Parikh, Kirsha Gordon, et al.
Kidney International|February 6, 2018
Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceCharles R Swanepoel, Mohamed G Atta, Vivette D D'Agati, et al.
Kidney International|May 29, 2025
Women and kidney health: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceGiorgina Barbara Piccoli, Sofia B Ahmed, Fadi Fakhouri, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 13, 2016
Illness Perceptions, Medication Beliefs, and Adherence to Antiretrovirals and Medications for Comorbidities in Adults With HIV Infection and Hypertension or Chronic Kidney DiseaseJeffrey J Weiss, Ioannis Konstantinidis, Anna Boueilh, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 21, 2023
Augmenting TCR signal strength and ICOS costimulation results in metabolically fit and therapeutically potent human CAR Th17 cellsMegan M Wyatt, Logan W Huff, Michelle H Nelson, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2006
Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malariaKatherine T Andrews, David P Fairlie, Praveen K Madala, et al.
Journal of AOAC International|April 16, 2004
Validation of three rapid screening methods for detection of verotoxin-producing Escherichia coli in foods: interlaboratory studyKatherine L Capps, Emiline M McLaughlin, Alistair W A Murray, et al.
Open Forum Infectious Diseases|October 30, 2019
Impact of Tenofovir-Based Pre-exposure Prophylaxis on Biomarkers of Bone Formation, Bone Resorption, and Bone Mineral Metabolism in HIV-Negative AdultsThomas L Nickolas, Michael T Yin, Ting Hong, et al.
Pageof 35

Showing results (311-320 of 345) with videos related to

Sort By:
Pageof 35
JCI Insight|April 20, 2017
β-catenin and PI3Kδ inhibition expands precursor Th17 cells with heightened stemness and antitumor activityKinga Majchrzak, Michelle H Nelson, Jacob S Bowers, et al.
Kidney International|May 2, 2024
Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIVAnnegret Pelchen-Matthews, Amanda Mocroft, Lene Ryom, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 18, 2012
Comorbid diabetes and the risk of progressive chronic kidney disease in HIV-infected adults: data from the Veterans Aging Cohort StudyRaj K Medapalli, Chirag R Parikh, Kirsha Gordon, et al.
Kidney International|February 6, 2018
Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceCharles R Swanepoel, Mohamed G Atta, Vivette D D'Agati, et al.
Kidney International|May 29, 2025
Women and kidney health: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceGiorgina Barbara Piccoli, Sofia B Ahmed, Fadi Fakhouri, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 13, 2016
Illness Perceptions, Medication Beliefs, and Adherence to Antiretrovirals and Medications for Comorbidities in Adults With HIV Infection and Hypertension or Chronic Kidney DiseaseJeffrey J Weiss, Ioannis Konstantinidis, Anna Boueilh, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 21, 2023
Augmenting TCR signal strength and ICOS costimulation results in metabolically fit and therapeutically potent human CAR Th17 cellsMegan M Wyatt, Logan W Huff, Michelle H Nelson, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2006
Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malariaKatherine T Andrews, David P Fairlie, Praveen K Madala, et al.
Journal of AOAC International|April 16, 2004
Validation of three rapid screening methods for detection of verotoxin-producing Escherichia coli in foods: interlaboratory studyKatherine L Capps, Emiline M McLaughlin, Alistair W A Murray, et al.
Open Forum Infectious Diseases|October 30, 2019
Impact of Tenofovir-Based Pre-exposure Prophylaxis on Biomarkers of Bone Formation, Bone Resorption, and Bone Mineral Metabolism in HIV-Negative AdultsThomas L Nickolas, Michael T Yin, Ting Hong, et al.
Pageof 35